Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B4e60df0400895e6932465a729a9666d5> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B4e60df0400895e6932465a729a9666d5 NCIT_P378 "NCI" @default.
- B4e60df0400895e6932465a729a9666d5 type Axiom @default.
- B4e60df0400895e6932465a729a9666d5 annotatedProperty IAO_0000115 @default.
- B4e60df0400895e6932465a729a9666d5 annotatedSource NCIT_C173044 @default.
- B4e60df0400895e6932465a729a9666d5 annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with nivolumab and relatlimab in patients with progressive neoplastic disease following immune checkpoint inhibitor therapies targeting either PD1 (PDCD1) or PD-L1 (CD247) that are LAG3 positive and have mismatch repair deficiency." @default.